Direkt zum Inhalt
Merck

Turnover of BRCA1 involves in radiation-induced apoptosis.

PloS one (2011-01-11)
Weijun Liu, Wenjun Zong, George Wu, Takeo Fujita, Wenqi Li, Judy Wu, Yong Wan
ZUSAMMENFASSUNG

Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susceptibility to tumorigenesis. The function of BRCA1 is to regulate critical cellular processes, including cell cycle progression, genomic integrity, and apoptosis. Studies on the regulation of BRCA1 have focused intensely on transcription and phosphorylation mechanisms. Proteolytic regulation of BRCA1 in response to stress signaling remains largely unknown. The manuscript identified a novel mechanism by which BRCA1 is regulated by the ubiquitin-dependent degradation in response to ionization. Here, we report that severe ionization triggers rapid degradation of BRCA1, which in turn results in the activation of apoptosis. Ionization-induced BRCA1 turnover is mediated via an ubiquitin-proteasomal pathway. The stabilization of BRCA1 significantly delays the onset of ionization-induced apoptosis. We have mapped the essential region on BRCA1, which mediates its proteolysis in response to ionization. Moreover, we have demonstrated that BRCA1 protein is most sensitive to degradation when ionization occurs during G2/M and S phase. Our results suggest that ubiquitin-proteasome plays an important role in regulating BRCA1 during genotoxic stress. Proteolytic regulation of BRCA1 involves in ionization-induced apoptosis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Actidion, from microbial, ≥94% (TLC)
Sigma-Aldrich
Propidiumjodid, ≥94.0% (HPLC)
Sigma-Aldrich
Cycloheximid, ≥95% (HPLC)
Sigma-Aldrich
Giemsa-Färbung, modifizierte Lösung, according to Giemsa
Sigma-Aldrich
Giemsa-Färbung, modifizierte Lösung, (for the staining (of cellular blood components and blood parasites))
Sigma-Aldrich
Actidion, Biotechnology Performance Certified
Sigma-Aldrich
Propidiumjodid, ≥94% (HPLC)
Supelco
Actidion, PESTANAL®, analytical standard